First-in-kind Singapore study to deliver insights into heart disease, diabetes, cancer, and other chronic diseases BC Platforms (BCP), a global leader in healthcare data management and analytics, today announced it has been selected as the platform of choice to analyse and manage data collected from the Health for Life in Singapore (HELIOS) study, which forms part of […]

Whole-genome sequencing of 35,000 de-identified, diverse genomic DNA samples will begin this month SAN DIEGO — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced an agreement with Amgen, a global biopharmaceutical company, to whole-genome sequence […]

Investment will double capacity to produce active pharmaceutical ingredients used in therapeutics for a broad range of diseases SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nucleic acids in response to rapid growth of the $1 billion market and strong […]

MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of highly accurate sequencing solutions, today announced a collaboration with the University of Tokyo, Graduate School of Medicine to study the use of long-read sequencing and novel bioinformatics methods in the hopes of better understanding the genetic causes of certain rare diseases in individuals and cohorts within the Japanese population. […]

Verogen a proven leader in equipping forensic science laboratories and criminal investigators to use next-generation sequencing (NGS) to gain deeper insights Addition of Verogen strengthens QIAGEN leadership in fast-growing field of Human ID / forensics anchored by sample collection and preparation, genetic testing analysis and workflow automation Deal builds on partnership launched in 2021 to distribute […]

• FiberSmart® is Genomic Vision’s Artificial Intelligence (AI) powered and fully integrated software automating genomic analysis • FiberSmart® leverages cutting-edge AI to rapidly analyze DNA replication kinetics and provide a seamless user experience • FiberSmart platform was successfully tested by AstraZeneca and the Fritz Lipmann Institute Bagneux (France) – Genomic Vision (FR0011799907 – GV, – […]

Novogene announced the addition of Illumina’s latest high-throughput sequencing system NovaSeq™ X Plus and PacBio’s Revio™ long-read sequencing system to its lineup of sequencing platforms. These systems will be deployed in Novogene’s regional lab facilities and will be available to its global customer base. Novogene is a trusted genomics partner to scientists worldwide and provides access to the latest genomics tools […]

Dublin, Ireland: ERS Genomics announced that its first Canadian patent, CA 2872241, with broad claims to compositions and methods of using CRISPR/Cas9 in humans, animals, plants, and microbes has been granted to the CVC group. CVC stands for University of California, University of Vienna, and Emmanuelle Charpentier and is the acronym used to describe the […]

Partnership to leverage the Helix® Laboratory Platform powered by QIAGEN’s biopharma relationships, NGS capabilities, and global regulatory expertise Addressing health burden in neuro-degenerative diseases, cardio-vascular diseases, and auto-immune and inflammatory diseases that affect hundreds of millions globally Combined offerings include accelerated patient recruitment, real world evidence and diagnostic solutions using NGS and PCR technologies VENLO, Netherlands […]

Innovative chemistries enable simultaneous genomic and epigenomic profiling on the same sample, yielding greater insights for precision medicine SANTA CLARA, Calif.–Agilent Technologies Inc. (NYSE: A) today announced the acquisition of Avida Biomed, an early-stage life sciences company that develops high-performance target enrichment workflows with unique capabilities for clinical researchers utilizing next-generation sequencing (NGS) approaches to […]